Bevacizumab treatment of meningeal melanoma metastases

BACKGROUND: Melanoma patients with metastatic growth in the meninges have poor prognosis and few treatment options. Although treatment with BRAF inhibitors or immune checkpoint inhibitors has provided promising results, most patients with advanced melanoma are resistant to these treatments and devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonsen, Trude G., Gaustad, Jon-Vidar, Rofstad, Einar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947957/
https://www.ncbi.nlm.nih.gov/pubmed/31915016
http://dx.doi.org/10.1186/s12967-020-02212-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947957/
https://www.ncbi.nlm.nih.gov/pubmed/31915016
http://dx.doi.org/10.1186/s12967-020-02212-3

Ejemplares similares